Table 2.

Centers for Disease Control and Prevention recommendations for immunization in hematopoietic stem cell transplant recipients

Vaccine	Schedule
23-valent pneumococcal polysaccharide	12 and 24 months
Haemophilus influenzae type b conjugate	12, 14, and 24 months
Varicella zoster virus	Contraindicated
Influenza	Yearly lifelong resuming ≥ 6 months post HCST
Tetanus-diphtheria toxoid	12,14, and 24 months
Inactivated polio	12,14, and 24 months
Hepatitis B	12,14, and 24 months
Hepatitis A	Routine administration not recommended
Meningococcal	Routine administration not recommended
MMR	≥ 24 months if immunocompetent

Data from reference 4. Hematopoietic stem cell transplant (HSCT) recipients are considered immunocompetent at 24 months after HSCT if they are not on immunosuppresive therapy and do not have graft-versus-host-disease